Cervical screening and human papillomavirus

Australian Family Physician

Volumn 34, Issue 7, 2005, Pages 578-580

  Sheary, Belinda ^a   Dayan, Linda ^b,c  

^a Royal North Shore Hospital ^*

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c MANLY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MICROBIOLOGY; PAPILLOMA VIRUS; PATHOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIRUS INFECTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT EDUCATION; PRACTICE GUIDELINES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 25144468944     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The National Cervical Screening Program. Department of Health and Aged Care. Audit Report No.50, 2000-2001. Commonwealth of Australia 2001. Available at: www.anao.gov.au/Website.nsf/Publications/4A256AE90015F69BCA256A6C00057874/.
2. Tracey E, Chen W, Sitas F. Cancer in New South Wales incidence and mortality 2002. NSW Central Cancer Registry. Cancer Research and Registers Division. The Cancer Council NSW, 2004.
3. NSW Cervical Screening Program and the NSW Pap Test Register. Annual Statistical Report 2002. Sydney: Westmead Hospital, 2003. Available at: www.csp.nsw.gov.au.
4. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
5. Sedlacek T. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol 1999;42:206-20.
6. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high risk area for cervical cancer. J Infect Dis 1999;180:1415-23.
7. Richardson H, Kelsall G, Tellier P, et al. The natural history of type specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485-90.
8. Moscicki A-B, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Paediatr 1998;132:277-84.
9. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
10. Brotherton JML, McIntyre PB. Planning for human papillomavirus vaccines in Australia. Report of a research group meeting. Commun Dis Intell 2004;28:249-54.
11. Screening to prevent cervical cancer. Guidelines for the management of asymptomatic women with screen detected abnormalities. January 2005. Available at: www.csp.nsw.gov.au/nhmrc//doc4comment.php.
12. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
13. Moscicki A-B, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low grade squamous intraepithelial lesion development in young females. JAMA 2001;285:2995-3002.
14. Woodman CBJ, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
15. McCaffery K, Forrest S, Waller J, et al. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Carribean and white British women in the UK. Br J Cancer 2003;88:42-6.
16. Dietsch E, Gibb H, Francis K. Abnormal Pap test results and the rurality factor. Aust J Rural Health 2003;11:50-6.
17. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-56.
18. Hogewoning CJA, Bleeker MCG, van den Brule AJC, et al. Condom use promotes regressionof cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomised clinical trial. Int J Cancer 2003;107:811-6.
19. Condoms or abstinence for one year then retest for HPV? J Low Genit Tract Dis 2001;5:99-101.
20. Manhart L, Koutsky L. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia?: A meta-analysis. Sex Trans Dis 2002;29:725-35.
21. Idestrom M, Milson I, Andersson-Ellstrom A. Women's experience of coping with a positive Pap smear: a register based study of women with two consecutive Pap smears reported as CIN1. Acta Obstet Gynecol Scand 2003;82:756-61.
22. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda system. Obstet Gynecol 1992;79:675-82.
23. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4.
24. Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CRA. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear. Med J Aust 1997;167:466-9.
25. Gray SH, Walzer TB. New strategies for cervical cancer screening in adolescents. Curr Opin Pediatr 2004;16:344-9.
26. Dickinson JA. Cervical Screening: time to change the policy. Med J Aust 2002;176:547-50.
27. Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Liquid based cervical cytologic smear study and conventional Papanicolaou smears: a meta-analysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 2001;185:308-17.
28. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society. Guidelines for the early detection of cervical neoplasia and cancer. Journal of Lower Genital Tract Disease 2003;7:67-86.
29. Waxman A. New cervical cancer screening guidelines: do they signal the end of the annual pap test?. J Low Genit Tract Dis 2004;8:87-90.
30. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-6.